When nanoparticles are used for drug delivery, they often end up in the liver or spleen instead of the intended target.
A team led by Jacob S. Brenner and Vladimir Muzykantov of the University of Pennsylvania now shows that nanocarrier delivery can be improved by the having the nanocarriers “hitchhike” on red blood cells (Nat. Commun. 2018, DOI: 10.1038/s41467-018-05079-7). The researchers withdrew red blood cells from mice and incubated them with nanoparticles, which adsorbed on the cell surface.
They then injected the cells back into the animals through arterial catheters. When injected this way, the nanocarriers accumulate in the first organ they encounter downstream from the injection site. The researchers think the narrow capillaries cause the nanoparticles to detach from the blood cells and transfer to the cells lining the capillaries.
Image Credit: Nat. Commun
News This Week
NanoApps Medical Near-Term Projects
NanoApps Medical is investigating the possibility that superparamagnetic nanoparticles (SPIONs) and other classes of nanoparticles (e.g., gold coated nanoshells) might have the capacity to target cancerous tumors, metastasizing cancer cells, pathogens, etc. to deactivate/eliminate [...]
‘Please do not switch me off!’ People heed begging robot
If a little humanoid robot begged you to not shut it off, would you show compassion? In an experiment designed to investigate how people treat robots when they act like humans, many participants struggled [...]
How Artificial Intelligence is Changing Radiology, Pathology
Artificial intelligence and machine learning tools have the potential to analyze large datasets and extract meaningful insights to enhance patient outcomes, an ability that is proving helpful in radiology and pathology. Images obtained by [...]
Nanoparticle-Based Combination Therapy to Treat Breast, Prostate Cancer
Researchers at the University of East Anglia have developed a new nanoparticle-based cancer therapy to deliver a combination therapy directly to cancer cells. The new therapy, which has been demonstrated to make prostate cancer [...]
AI: ChronWell CEO On Why Consolidation in Healthcare Is A Good Thing
When Joe Rubinsztain started gMed, he was admittedly young—only a few years removed from medical school— and he just didn’t understand leadership that well. “I needed to be abreast of everything and understand everything [...]
Artificial Intelligence for Medical Imaging Market to Top $2B
Healthcare organizations are likely to see a rapidly growing market around artificial intelligence tools for medical imaging, a new report predicts. The market for artificial intelligence (AI) tools to process and analyze medical imaging [...]
Tuberculosis is a killer, but scientists are fighting back with nanobots
Tuberculosis, a bacterial disease which predominantly affects the lungs, isn’t all that common a sight in the United States. On average, fewer than 10,000 cases are reported each year in a country with [...]
Integrated sensor could monitor brain aneurysm treatment
Implantation of a stent-like flow diverter can offer one option for less invasive treatment of brain aneurysms – bulges in blood vessels – but the procedure requires frequent monitoring while the vessels heal. Now, [...]
Leave A Comment